Iacobaeus, E.; Kadri, N.; Lefsihane, K.; Boberg, E.; Gavin, C.; Törnqvist Andrén, A.; Lilja, A.; Brundin, L.; Blanc, K.L.
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study. J. Clin. Med. 2019, 8, 2102.
https://doi.org/10.3390/jcm8122102
AMA Style
Iacobaeus E, Kadri N, Lefsihane K, Boberg E, Gavin C, Törnqvist Andrén A, Lilja A, Brundin L, Blanc KL.
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study. Journal of Clinical Medicine. 2019; 8(12):2102.
https://doi.org/10.3390/jcm8122102
Chicago/Turabian Style
Iacobaeus, Ellen, Nadir Kadri, Katia Lefsihane, Erik Boberg, Caroline Gavin, Anton Törnqvist Andrén, Anders Lilja, Lou Brundin, and Katarina Le Blanc.
2019. "Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study" Journal of Clinical Medicine 8, no. 12: 2102.
https://doi.org/10.3390/jcm8122102
APA Style
Iacobaeus, E., Kadri, N., Lefsihane, K., Boberg, E., Gavin, C., Törnqvist Andrén, A., Lilja, A., Brundin, L., & Blanc, K. L.
(2019). Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study. Journal of Clinical Medicine, 8(12), 2102.
https://doi.org/10.3390/jcm8122102